Same Drug Class

Ipilimumab vs Methotrexate

Ipilimumab vs Methotrexate: Overview

This comparison examines the pharmacological differences between Ipilimumab and Methotrexate.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5.

Molecular Weight: Methotrexate — 454.4400 g/mol.

Type: Ipilimumab — Antibody; Methotrexate — Small molecule.